Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: A flexible-dose, open-label pilot trial
Authors:
- M.A. KatzmanMKM.A. Katzman
- M. VermaniMVM. Vermani
- L. JacobsLJL. Jacobs
- M. MarcusMMM. Marcus
- B. KongBKB. Kong
- S. LessardSLS. Lessard
- W. GalarragaWGW. Galarraga
- L. StruzikLSL. Struzik
- A. GendronAGA. Gendron
- 1 December 2008
- journal article
- research article
- Published by Elsevier in Journal of Anxiety Disorders
- Vol. 22 (8) , 1480-1486
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Quetiapine plus SSRI in treatment-resistant depression: possible mechanismsPsychopharmacology, 2006
- Adjunctive Risperidone in Generalized Anxiety DisorderThe Journal of Clinical Psychiatry, 2005
- Escitalopram in the treatment of generalized anxiety disorderExpert Review of Neurotherapeutics, 2005
- A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II DepressionAmerican Journal of Psychiatry, 2005
- Low-Dose Risperidone and Quetiapine as Monotherapy for Comorbid Anxiety and DepressionThe Journal of Clinical Psychiatry, 2005
- Quetiapine Augmentation in Obsessive-Compulsive Disorder Resistant to Serotonin Reuptake InhibitorsThe Journal of Clinical Psychiatry, 2005
- The promise of atypical antipsychoticsPostgraduate Medicine, 2004
- A Double-Blind, Randomized, Placebo-Controlled Trial of Quetiapine Addition in Patients With Obsessive-Compulsive Disorder Refractory to Serotonin Reuptake InhibitorsThe Journal of Clinical Psychiatry, 2004
- Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trialsCurrent Medical Research and Opinion, 2004
- Augmentation of Serotonin Reuptake Inhibitors in Refractory Obsessive-Compulsive Disorder Using Adjunctive OlanzapineThe Journal of Clinical Psychiatry, 2004